Brief: Ascelia Pharma Receives FDA Complete Response Letter For Orviglance NDA
03/07/2026 14:10
BRIEF-Ascelia Pharma Receives FDA Complete Response Letter For Orviglance NDA July 3 (Reuters) - Ascelia Pharma AB ACELP.ST:
RECEIVES FDA COMPLETE RESPONSE LETTER FOR ORVIGLANCE NDA
FDA REQUESTS ADDITIONAL CLINICAL DATA AND DOCUMENTATION FOR ORVIGLANCE NDA
Source text: ID:nMFN8jglms
Further company coverage: ACELP.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))